Xiao Guang Zhao

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report

Darell D. Bigner, M. Brown, R. Edward Coleman et al. · Journal of Neuro-Oncology · 1995 · 126 citations

Neuro-oncology, 2-A Preliminary Report, Tumoral Pathology +8

Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.

Gamal Akabani, David A. Reardon, R. Edward Coleman et al. · PubMed · 2005 · 95 citations

Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.

David A. Reardon, Jennifer A. Quinn, Gamal Akabani et al. · PubMed · 2006 · 51 citations

Improved Brain Delivery of Pueraria Flavones Via Intranasal Administration Of Borneol-Modified Solid Lipid Nanoparticles

Liping Wang, Xiao Guang Zhao, Junfeng Du et al. · Nanomedicine · 2019 · 50 citations · Full text

Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

Luting Wang, Lin Xu, Junfeng Du et al. · Drug Delivery · 2021 · 41 citations · Full text